Ítem
Acceso Abierto

Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease

Mostrar el registro sencillo de la publicación
dc.creatorNucci, Marciospa
dc.creatorCelis-Ramírez, Adriana Marcelaspa
dc.creatorGómez Giraldo, Beatríz Lucíaspa
dc.creatorRojas, Ritaspa
dc.creatorCornejo-Juárez, Patriciaspa
dc.creatorRiera, Fernandospa
dc.creatorVergara, Erika Paolaspa
dc.creatorCuéllar, Luis E.spa
dc.creatorCorzo-León, Dora E.spa
dc.creatorThompson, Luisspa
dc.creatorCuervo-Maldonado, Sonia Isabelspa
dc.creatorEnciso Olivera, Leonardospa
dc.creatorDiaz-Brochero, Cándidaspa
dc.creatorNocua-Báez, Laura Cristinaspa
dc.creatorVarón-Vega, Fabiospa
dc.creatorÁlvarez-Moreno, Carlos Arturospa
dc.creatorCapone, Domenicospa
dc.creatorRabagliati, Ricardospa
dc.creatorValderrama-Rios, Martha Carolinaspa
dc.creatorRodríguez-Lugo, Diego Andrésspa
dc.creatorCortés, Jorge Albertospa
dc.date.accessioned2025-07-21T16:42:01Z
dc.date.available2025-07-21T16:42:01Z
dc.date.created2025-02-24spa
dc.date.issued2025-02-24spa
dc.description.abstractAspergillosis is a disease caused by the filamentous fungus Aspergillus spp. with a spectrum of clinical presentation that includes invasive and noninvasive forms. The invasive clinical presentation of aspergillosis most frequently affects people with compromised immune systems. In patients with oncohematologic pathology, invasive lung aspergillosis is a significant opportunistic mycosis, because it occurs frequently and has a major impact on morbidity, mortality, and high costs. The global problem of antimicrobial resistance, to which improper use of antifungals contributes, has put Aspergilus spp. in the spotlight, so it is important to generate guidelines for guidance in the proper use of antifungals in the management of invasive lung aspergillosis, to obtain better clinical outcomes and promote rational use of antifungals. This guideline contains recommendations for diagnosing and treating invasive lung aspergillosis in patients with oncohematologic disease, based on evidence and defined through a participatory process of expert consensus, for the Latin American context.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.bjid.2025.104517spa
dc.identifier.issn1413-8670spa
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/46060
dc.language.isoengspa
dc.publisherSociedade Brasileira de Infectologiaspa
dc.relation.ispartofBrazilian Journal of Infectious Diseases 29 (2025)spa
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S1413867025000200?via%3Dihubspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourceBrazilian Journal of Infectious Diseasesspa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordInvasive pulmonary aspergillosiseng
dc.subject.keywordHematologic neoplasmseng
dc.titleEvidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic diseasespa
dc.typearticlespa
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersionspa
dc.type.spaArtículo de Investigaciónspa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
Evidence-based_clinical_standard_for_the_diagnosis.pdf
Tamaño:
1.99 MB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Artículos